XY8-30930-05061
2 vaccinations
4 coded responses
11 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 945 / CA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-27
Dose 1 — Pfizer-BioNTech
-
2021-04-12
Registered in v-safe
- 2021-04-12
-
2021-04-17
Survey response — 21 day, dose 1MedDRA: Arthralgia, Oral herpes, Pre-existing disease, Rheumatoid arthritis, Skin exfoliation — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-17
Report sent to call center — 21 day, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-04-24
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia — Feeling: Fair · Joint pains · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Good · Joint painsMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-01
Survey response — 7 day, dose 2MedDRA: Arthralgia — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-07
- 2021-05-14
- 2021-05-23
- 2021-05-28
- 2022-04-07
- 2022-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-17 | Unsuccessful | |
| 2021-04-24 | Unsuccessful |
Free text
Release 7
Symptoms: After one and a half days following my first vaccination, I developed a severe rheumatoid arthritis flareup, immune issues such as scaling, cold sore. Have been in tremendous joint pain, and I am being treated with anti-inflammatories as a result.
Release 8
Systemic reaction (other): Join 10 minutes joint tenderness ever since first vaccination, pain medication has alleviated the joint pain symptoms
Systemic reaction (other): Symptoms are receding, whether by pain meds or time. But Im a lot happier, and had no worsening effects from the second vaccine.
Systemic reaction (other): Being treated for joint pain and happily no (further) symptoms arose from second vaccine.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Oral herpes | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rheumatoid arthritis | ✓ | ✓ | ✓ |
| SD | Skin exfoliation | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release